Evidence map›Paper›PMID 37608372›Full record

ArticleVirology journal2023

Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar.

Gheyath K Nasrallah, Soha R Dargham, Duaa W Al-Sadeq, Fathima H Amanullah, Farah M Shurrab, Parveen B Nizamuddin, Hiam Chemaitelly, Houssein H Ayoub, Sami Abdeen, Ashraf Abdelkarim and 38 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 5 institutions in 3 countries.

Gheyath K NasrallahBiomedical Research Center, Qatar University, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.
Soha R DarghamInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
Duaa W Al-SadeqBiomedical Research Center, Qatar University, Doha, Qatar.
Fathima H AmanullahBiomedical Research Center, Qatar University, Doha, Qatar.
Farah M ShurrabBiomedical Research Center, Qatar University, Doha, Qatar.
Parveen B NizamuddinBiomedical Research Center, Qatar University, Doha, Qatar.
Hiam ChemaitellyInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
Houssein H AyoubMathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar.
Sami AbdeenHamad Medical Corporation, Doha, Qatar.
Ashraf AbdelkarimHamad Medical Corporation, Doha, Qatar.
Faisal DaraanMinistry of Public Health, Doha, Qatar.
Ahmed IsmailMinistry of Public Health, Doha, Qatar.
Nahid MostafaMinistry of Public Health, Doha, Qatar.
Mohamed SahlHamad Medical Corporation, Doha, Qatar.
Jinan SulimanHamad Medical Corporation, Doha, Qatar.
Elias TayarHamad Medical Corporation, Doha, Qatar.
Hasan Ali KasemQatar Red Crescent Society, Doha, Qatar.
Meynard J A AgsalogQatar Red Crescent Society, Doha, Qatar.
Bassam K AkkarathodiyilQatar Red Crescent Society, Doha, Qatar.
Ayat A AlkhalafQatar Red Crescent Society, Doha, Qatar.
Mohamed Morhaf M H AlaksharQatar Red Crescent Society, Doha, Qatar.
Abdulsalam Ali A H Al-QahtaniQatar Red Crescent Society, Doha, Qatar.
Monther H A Al-ShedifatQatar Red Crescent Society, Doha, Qatar.
Anas AnsariQatar Red Crescent Society, Doha, Qatar.
Ahmad Ali AtaallaQatar Red Crescent Society, Doha, Qatar.
Sandeep ChouguleQatar Red Crescent Society, Doha, Qatar.
Abhilash K K V GopinathanQatar Red Crescent Society, Doha, Qatar.
Feroz J PoolakundanQatar Red Crescent Society, Doha, Qatar.
Sanjay U RanbhiseQatar Red Crescent Society, Doha, Qatar.
Saed M A SaefanQatar Red Crescent Society, Doha, Qatar.
Mohamed M ThaivalappilQatar Red Crescent Society, Doha, Qatar.
Abubacker S ThoyalilQatar Red Crescent Society, Doha, Qatar.
Inayath M UmarQatar Red Crescent Society, Doha, Qatar.
Einas Al KuwariHamad Medical Corporation, Doha, Qatar.
Peter CoyleBiomedical Research Center, Qatar University, Doha, Qatar.
Andrew JeremijenkoHamad Medical Corporation, Doha, Qatar.
Anvar Hassan KaleeckalHamad Medical Corporation, Doha, Qatar.
Hanan F Abdul RahimDepartment of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Hadi M YassineBiomedical Research Center, Qatar University, Doha, Qatar.
Asmaa A Al ThaniBiomedical Research Center, Qatar University, Doha, Qatar.
Odette ChaghouryHamad Medical Corporation, Doha, Qatar.
Mohamed Ghaith Al KuwariPrimary Health Care Corporation, Doha, Qatar.
Elmoubasher FaragMinistry of Public Health, Doha, Qatar.
Roberto BertolliniMinistry of Public Health, Doha, Qatar.
Hamad Eid Al RomaihiMinistry of Public Health, Doha, Qatar.
Abdullatif Al KhalHamad Medical Corporation, Doha, Qatar.
Mohamed H Al-ThaniMinistry of Public Health, Doha, Qatar.
Laith J Abu-RaddadInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar. lja2002@qatar-med.cornell.edu.
Hamad Medical Corporation · QAQatar University · QAMinistry of Public Health · QAWeill Cornell Medical College in Qatar · QAPrimary Health Care · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLimited data exists on herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections in migrant populations. This study investigated HSV-1 and HSV-2 seroprevalences and associations among craft and manual workers (CMWs) in Qatar who constitute 60% of Qatar's population.

methodsA national population-based cross-sectional seroprevalence survey was conducted on the CMW population, all men, between July 26 and September 9, 2020. 2,612 sera were tested for anti-HSV-1 IgG antibodies using HerpeSelect 1 ELISA IgG kits and for anti-HSV-2 IgG antibodies using HerpeSelect 2 ELISA IgG kits (Focus Diagnostics, USA). Univariable and multivariable logistic regression analyses were conducted to identify associations with HSV-1 and HSV-2 infections.

resultsSerological testing identified 2,171 sera as positive, 403 as negative, and 38 as equivocal for HSV-1 antibodies, and 300 sera as positive, 2,250 as negative, and 62 as equivocal for HSV-2 antibodies. HSV-1 and HSV-2 seroprevalences among CMWs were estimated at 84.2% (95% CI 82.8-85.6%) and 11.4% (95% CI 10.1-12.6%), respectively. HSV-1 infection was associated with nationality, educational attainment, and occupation. HSV-2 infection was associated with age, nationality, and educational attainment.

conclusionsOver 80% of CMWs are infected with HSV-1 and over 10% are infected with HSV-2. The findings highlight the need for sexual health programs to tackle sexually transmitted infections among the CMW population.

Indexed as

Herpes SimplexHerpesvirus 1, HumanTransients and MigrantsAntibodies, ViralCross-Sectional StudiesHerpesvirus 2, HumanHumansImmunoglobulin GMaleQatarSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin GCross sectional studyGenital herpesGenital ulcer diseaseHSV-1HSV-2MigrantsPrevalenceQatarSurvey

Identifiers

PMID37608372
PMCPMC10463979
OpenAlexW4386068748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.